Efficacy of oral sildenafil 1N patients with erectile dysfunction after radiotherapy for carcinoma of the prostate

Urology

Volumn 53, Issue 4, 1999, Pages 775-778

  Zelefsky, Michael J ^a   Mckee, Andrea B ^a   Lee, Henry ^a   Leibel, Steven A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG TOLERANCE; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; IMPOTENCE; INCIDENCE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; SEXUAL FUNCTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSTATIC NEOPLASMS; RADIOTHERAPY;

EID: 0033119173     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00594-9     Document Type: Article

References (17)

1. Bagshaw M.A., Cox R.S., Ray G.R. Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr. 7:1988;47-60.
2. Asbell S.O., Krall J.M., Pilepich M.V., et al. Elective pelvic irradiation in stages A2, B carcinoma of the prostate analysis of RTOG 7706 . Int J Radiat Oncol Biol Phys. 15:1988;1307-1316.
3. Roach M., Chinn D.M., Holland J., et al. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 35:1996;869-874.
4. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
5. Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 14:1996;449-453.
6. Stock R.G., Stone N.N., Iannuzzi C. Sexual potency following interactive ultrasound guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 35:1996;267-272.
7. Banker F.L. The preservation of potency after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 15:1988;219-220.
8. Helgason A.R., Fredickson M., Adolfsson J., et al. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol Phys. 32:1995;33-39.
9. Austoni E., Bellorofonte C., Mantovani F. Improved results with intracavernous vasoactive drug infusion following new surgical techniques for vasculogenic impotence. World J Urol. 5:1987;182-185.
10. Lerner S.E., Melman A., Christ G.J. A review of erectile dysfunction new insights and more questions . J Urol. 149:1993;1246-1255.
11. Pierce D.J., Whittington R., Hanno P.M. Pharmocologic erection with intracavernosal injection for men with sexual dysfunction following irradiation a preliminary report . Int J Radiat Oncol Biol Phys. 21:1991;1311-1314.
12. Galea G., Britanico J., Vapnek J.M. Disappointing results for transurethral alprostadil in a V.A. impotence clinic. J Urol. 159:1998;236.
13. Hanson-Divers C., Jackson S., Lue T., et al. Health outcome variables important to patients in the treatment of erectile dysfunction. J Urol. 159:1998;1541-1547.
14. Boolell M., Allen M.J., Ballard S.A., et al. Sildenafil an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction . Int J Impot Res. 8:1996;47-52.
15. Goldstein I., Lue T.F., Padma-Nathan H., et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 338:1998;1397-1404.
16. Zelefsky M.J., Eid J.F. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys. 40:1998;129-133.
17. Boolell M., Pearson J., Gingell C., et al. Sildenafil (Viagra) is an efficacious oral therapy in diabetic patients with erectile dysfunction (ED). Int J Impot. 8:1996;47-52.